Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 7905101.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Oxidative modification of low-density lipoprotein (LDL) may be atherogenic. We studied the time of onset of LDL oxidation (lag) in 18 postmenopausal women before and after intraarterial infusion of 17 beta-oestradiol, after 3 weeks' patch administration in 12 of these women, and 1 month after discontinuation in 10. The lag increased from baseline after acute infusion (from 134 [SD41] to 167 [36] min, p = 0.01) and after the patch (132 [31] to 178 [45] min, p = 0.009). After discontinuation of oestradiol, the lag returned to baseline. This study shows an antioxidant effect of physiological levels of 17 beta-oestradiol, which may contribute to an anti-atherogenic action.
Medical subject headings
- Antioxidants
- Estradiol
- Estrogen Replacement Therapy
- Lipid Peroxidation
- Lipoproteins, LDL
- Postmenopause